{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:02:46Z","timestamp":1780822966568,"version":"3.54.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,10,15]]},"DOI":"10.2169\/internalmedicine.9015-21","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:10:48Z","timestamp":1648851048000},"page":"3095-3100","source":"Crossref","is-referenced-by-count":5,"title":["Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung Disease"],"prefix":"10.2169","volume":"61","author":[{"given":"Yutaka","family":"Muto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sakayori","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okudela","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Sayama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kawasaki Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 27: 481-486, 2002.","DOI":"10.1165\/rcmb.2002-0023OC"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Prim 5: 16, 2019.","DOI":"10.1038\/s41572-019-0066-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Frazier AA, Franks TJ, Cooke EO, Mohammed TH, Pugatch FRD, Galvin JR. From the archives of the AFIP pulmonary alveolar proteinosis. Radiographics 28: 883-899, 2008.","DOI":"10.1148\/rg.283075219"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Prakash UBS, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 62: 499-518, 1987.","DOI":"10.1016\/S0025-6196(12)65477-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oh SJ, Choo JY, Lee KY, Kim JH, Yeom SK. Localized pulmonary alveolar proteinosis: two case reports. Balkan Med J 31: 257-260, 2014.","DOI":"10.5152\/balkanmedj.2014.13188"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Borie R, Danel C, Debray MP, et al. Pulmonary alveolar proteinosis. Eur Respir Rev 20: 98-107, 2011.","DOI":"10.1183\/09059180.00001311"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177: 752-762, 2008.","DOI":"10.1164\/rccm.200708-1271OC"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, McAdams HP.  "Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics 23: 1509-1519, 2003.","DOI":"10.1148\/rg.236035101"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cao M, Sheng J, Qiu X, et al. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study. BMC Pulm Med 19: 12-14, 2019.","DOI":"10.1186\/s12890-019-0960-1"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tachikawa R, Tomii K, Ueda H, et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration 83: 20-27, 2012.","DOI":"10.1159\/000329893"},{"key":"11","unstructured":"11. King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis 4: 411-419, 2009."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ashour M. Hemodynamic alterations in bronchiectasis: a base for a new subclassification of the disease. J Thorac Cardiovasc Surg 112: 328-334, 1996.","DOI":"10.1016\/S0022-5223(96)70258-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Awab A, Khan MS, Youness HA. Whole lung lavage-technical details, challenges and management of complications. J Thorac Dis 9: 1697-1706, 2017.","DOI":"10.21037\/jtd.2017.04.10"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pitcher HT, Harrison MA, Shaw C, Cowan SW, Hirose H, Cavarocchi N. Management considerations of massive hemoptysis while on extracorporeal membrane oxygenation. Perfusion 31: 653-658, 2016.","DOI":"10.1177\/0267659116651484"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Punatar AD, Kusne S, Blair JE, Seville MT, Vikram HR. Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infection 65: 173-179, 2012.","DOI":"10.1016\/j.jinf.2012.03.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166: 215-235, 2002.","DOI":"10.1164\/rccm.2109105"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imura Y, Yukawa N, Handa T, et al. Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease. Mod Rheumatol 28: 724-729, 2018.","DOI":"10.3109\/14397595.2016.1153443"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sato S, Akasaka K, Ohta H, et al. Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report. BMC Pulm Med 20: 4-9, 2020.","DOI":"10.1186\/s12890-020-1110-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Akasaka K, Tanaka T, Kitamura N, et al. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study. BMC Pulm Med 15: 1-9, 2015.","DOI":"10.1186\/s12890-015-0085-0"},{"key":"20","unstructured":"20. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EKL. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 176: 139-148, 2017."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yang Y, Liu Y, Huang L, et al. Clinical features and cytokine profile in myositis patients with anti-EJ autoantibodies detected by a novel immunoprecipitation assay. Biomed Res Int 2019: 1856180, 2019.","DOI":"10.1155\/2019\/1856180"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sasano H, Hagiwara E, Kitamura H, et al. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med 16: 1-11, 2016.","DOI":"10.1186\/s12890-016-0325-y"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/20\/61_9015-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T03:26:44Z","timestamp":1665804404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/20\/61_9015-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":22,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9015-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"article-number":"9015-21"}}